Real-time enrollment status for this platinum-resistant ovarian carcinoma clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 11:41 PM UTC
| NCT Number | NCT05225363 |
| Recruiting Status | Recruiting |
| Condition | Platinum-Resistant Ovarian Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 33 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | July 1, 2026 (2 weeks ago) |
As of July 20, 2026: Clinical trial NCT05225363 is currently recruiting participants. This phase1 study for platinum-resistant ovarian carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05225363 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05225363 was last updated 2 weeks ago (July 1, 2026). HelloStudys verifies this status automatically.